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Expansion of Hepatic Stem Cell Compartment
Boosts Liver Regeneration
Veronika Papp,1 Andra´s Ro´kusz,1 Katalin Dezs}o,1 Edina Bugyik,1 Vanessza Szabo´,1
Zolta´n Pa´vai,2 Sa´ndor Paku,1,3 and Pe´ter Nagy1
The hepatic stem cells reside periportally forming the canals of Hering in normal liver. They can be identified by
their unique immunophenotype in rat. The oval cells, the progenies of stem cells invade deep the liver paren-
chyma after activation and differentiate into focally arranged small—and eventually trabecularly ordered reg-
ular hepatocytes. We have observed that upon the completion of intense oval cell reactions narrow ductular
structures are present in the parenchyma, we propose to call them parenchymal ductules. These parenchymal
ductules have the same immunophenotype [cytokeratin (CK)7 -/CK19 +/alpha-fetoprotein (AFP) -/delta-like
protein (DLK) - ] as the resting stem cells of the canals of Hering, but different from them reside scattered in the
parenchyma. In our present experiments, we have investigated in an in vivo functional assay if the presence of
these parenchymal ductules has any impact on a progenitor cell driven regeneration process. Parenchymal
ductules were induced either by an established model of oval cell induction consisting of the administration of
necrogenic dose of carbontetrachloride to 2-acetaminofluorene pretreated rats (AAF/CCl4) or a large necrogenic
dose of diethylnitrosamine (DEN). The oval cells expanded faster and the foci evolved earlier after repeated
injury in the livers with preexistent parenchymal ductules. When the animals were left to survive for one more
year increased liver tumor formation was observed exclusively in the DEN treated rats. Thus, repeated oval cell
reactions are not necessarily carcinogenic. We conclude that the expansion of hepatic stem cell compartment
conceptually can be used to facilitate liver regeneration without an increased risk of tumorigenesis.
Introduction
It is well documented in humans, as well as in experi-mental animals that the stem cell compartment can restore
the liver parenchyma after extensive damage [1]. Un-
fortunately this process is often not efficient enough. The
presence of intense ductular reaction in the liver of patients
who die of fulminant hepatic failure indicates the activation of
the stem cells but obviously they are not able to restore ap-
propriate liver function [2]. The acceleration of the stem cell
fed regeneration would have important implications in clini-
cal medicine. We have been analyzing the 2-acetamino-
fluorene/partial hepatectomy (AAF/Ph) model [3] of liver
regeneration for several years [4,5]. In this widely used ex-
perimental model the AAF inhibits the regenerative activity of
the hepatocytes and the liver mass is restored by the partici-
pation of so called oval cells [6]. The oval cells form elongated
tubules, which are the extensions of canals of Hering [4]. Later,
the oval cells at the distal tip of these tubules gain higher
proliferative activity, while differentiating along the hepato-
cytic lineage. During this process the clusters of small dif-
ferentiating hepatocytes form foci [7]. This is a relatively
synchronized process with well-defined stages of regeneration
and differentiation. We have observed scattered ductules
(called parenchymal ductules further on) inside the liver lob-
ules 3months after the completion of this experiment [5], when
otherwise the normal histological structure of the liver was
restored. Interestingly, the cells constructing these ductules
express CK19 but do not CK7, alike the immunophenotype of
the normal canals of Hering, which are strictly confined to the
periportal space in rat [5]. The AAF/Ph experiment also serves
as promoter in the classical Solt-Farber chemical hepatocarci-
nogenesis model [8], when it is preceded by a single dose ad-
ministration of diethylnitrosamine (DEN). We have recently
demonstrated that the architecture of oval cell proliferation and
focus formation is identical whether DENwas orwas not given
to the rats [7]. However, while analyzing these experiments,we
had the impression that the oval cell proliferation/differentia-
tion process was brought forward after DEN treatment. Inter-
estingly, it is mentioned in the original description of the Solt-
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Farber model that ‘‘oval cells’’ were present in the periportal
zone after the DEN induced necrosis [9] (before the AAF ad-
ministration). No further attention was paid to these ductules
in the original report. They have not been characterized but
their short description is reminiscent to the parenchymal
ductules we have seen 3months after the AAF/Ph experiment.
These observations led us to analyze if (i) parenchymal duct-
ules are present in the rat liver after different injuries, (ii) there is
any similarity between the parenchymal ductules and canals of
Hering, (iii) the presence of the parenchymal ductules have any
impact on the regeneration induced by a repeated injury. Since
the oval cell reaction in the AAF/Ph and AAF/CCl4 experi-
ments have been shown comparable [10,11] and our experi-
mental design required repeated extensive parenchymal
injuries on the same animal, surgical partial hepatectomy has
been replaced by ‘‘chemical partial hepatectomy’’ with the
application of a necrogenic dose of CCl4.
Materials and Methods
Animal experiments
Male F344 rats were used for all experiments and were
kept under standard conditions. At least four animals were
used for each experimental time points. The animal study
protocols were conducted according to National Institutes of
Health guidelines for animal care.
Liver injury models. Traditional 2/3 surgical partial hep-
atectomy was performed [12].
Carbon tetrachloride: 2mL/kg (20% CCl4 dissolved in
sunflower oil) was given by gavage.
Allyl alcohol: 50mL/kg (diluted 1:40 in saline) was injected
intraperitoneally.
DEN 200mg/kg was injected intraperitoneally. Livers
were removed 14 days and 12 weeks after DEN adminis-
tration.
AAF/CCl4 experiment: 8mg/kg AAF was given by ga-
vage for 5 days. CCl4 treatment was given the next day as
described above and it was followed by five more doses of
AAF daily. Livers were removed 12 weeks after CCL4 ad-
ministration.
Repeated injury models. On the first group (2·AAF/
CCl4), AAF/CCl4 experiment was performed and 3 months
after the first CCl4 treatment the very same experiment was
repeated (Group I).
The second group (DEN-AAF/CCl4) was treated by a
single dose of DEN and 2 weeks later the AAF/CCl4 ex-
periment was performed (Group II).
The control group (AAF/CCl4, Group III) was stomach
tubed with the solvent only (parallel to Group I), saline was
injected into their peritoneal cavity together with the DEN
treatment of Group II and finally the AAF/CCl4 experiment
was performed. In other words, AAF/CCl4 experiment was
performed on three sets of rats but it was preceded by an-
other AAF/CCl4 experiment 3 months earlier (Group I) or
by DEN treatment 2 weeks earlier (Group II) or no pre-
treatment (Group III) (Fig. 1). The animals in each test
FIG. 1. Schematic representation of the in-
jury models. Group I, 2 ·AAF/CCl4; Group
II, DEN-AAF/CCl4; Group III, AAF/CCl4.
Table 1. Primary Antibodies and Fluorescent Dyes Used for the Immunohistochemical Studies
Antibody Species Manufacturer Catalog number Dilution
FITC-labeled pancytokeratin
(CK5,6,8,17 and 19)
Mouse monoclonal DAKO F0859 1:10
CK7 Mouse monoclonal Biogenex NU255UC 1:50
CK19 Mouse monoclonal Novocastra NCL-CK19 1:50
AFP Rabbit polyclonal DAKO A0008 1:100
DLK-1 Goat polyclonal R&D Systems AF1144 1:50
Laminin Rabbit polyclonal DAKO Z0097 1:200
SMA Mouse monoclonal DAKO M0851 1:50
OV-6 Mouse monoclonal R&D Systems MAB2020 1:100
TRITC-labeled streptavidin — Jackson Immunoresearch 016-090-084 1:100
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FIG. 2. (A) Representative image used to determine the area fraction of the OV6 positive ductules. (B) Scanned image of a whole
liver section stained for endogen biotin by streptavidin TRITC. The foci appearing as dark areas as the new hepatocytes have low
biotin content. Number and size of the foci were determined alongwith the area of the section to calculate the volume density of the
foci. Scale bar for (A) 200mm; (B) 1mm.
FIG. 3. (A) Liver cryosection 12 weeks after the AAF/CCl4 experiment stained for OV6 (green) and laminin (red). Note the
presence of scattered OV6 positive ductules apart from the portal tracts within the parenchyma. (B) Liver cryosection 14 days
after DEN treatment stained for pan cytokeratin (green) and laminin (red). Numerous strong cytokeratin positive ductules
surrounded by laminin positive basement membrane are present in the parenchyma. (C) Liver cryosection 12 weeks after
DEN treatment stained for OV6 (green) and laminin (red). Scattered OV6 positive ductules are present in the parenchyma. (D)
Liver cryosection 14 days after DEN treatment stained for OV6 (green) and laminin (red). Two parenchymal ductules are
visible (1,2), which are attached to hepatocytes. Insets show the U-shaped basement membrane bordering the terminal part of
these parenchymal ductules. Arrowheads point at the position where the basement membrane touches the hepatocyte. Asterisk
indicates portal vein. Scale bar for the insets: 10 mm. (E, F) Serial cryosections of a normal liver depicting a portal area. (E) is
stained for CK19 (green) and laminin (red). (F) is stained for CK7 (red) and laminin (blue). Arrows point at small ductules,
which are negative for CK7. Arrowheads points at the same type of ductules, which are surrounded by an U shaped basement
membrane. Note the large bile duct positive for both cytokeratins. Scale bar for (A–C) 200mm; (D–F) 50mm. CK, cytokeratin.
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groups were the same age (5 months) and had similar
weight when the AAF/CCl4 treatment was started. The rats
in different groups were sacrificed in identical time points.
The intensity of the regeneration (oval cell proliferation/
differentiation) was quantitatively characterized by mea-
suring the area occupied by OV6 positive oval cells and
determining the number of foci constructed by low biotin
containing new hepatocytes.
Carcinogenesis experiments. The above described experi-
ments were performed on additional animals. After com-
pleting the three sets of treatments, the rats were maintained
on regular conditions and sacrificed at 15 months age.
Thorough autopsy was performed and tumor suspicious le-
sions from the liver were fixed in formaldehyde for histo-
logical examination.
Immunohistochemistry
Frozen sections (15 mm) were fixed in methanol (- 20C)
and were incubated at room temperature (1 h) with a mixture
of the primary antibodies (Table 1), and then with appro-
priate secondary antibodies ( Jackson ImmunoResearch). All
samples were analyzed by confocal laser scanning micros-
copy using the Bio-Rad MRC-1024 system (Bio-Rad).
Morphometry
Determination of the area fraction occupied by OV6 positive
ductules. Sections stained for OV6 were captured by a Bio-
Rad confocal microscope using a 10 · objective (Fig. 2A). The
micrographs were transformed into black and white and the
area occupied by OV6 positive oval cells was measured us-
ing the IMAN 2.0 program (KFKI). Livers from three to four
animals were analyzed at each time-point.
Determination of volume density of foci. Sections were in-
cubated with streptavidin-TRITC to highlight the endogen
biotin of the hepatocytes and were scanned using the Mirax
scanner (3DHISTECH). Small hepatocytes forming foci, due
to their low endogen biotin content, appear as dark circles on
the sections (Fig. 2B). The area of the section (A), the number
(N) and diameter (d) of the foci were determined by the
Mirax Viewer 1.11 program (3DHISTECH). Numerical den-
sity (Na =N/A) of the foci was calculated for each section.
The real average diameter of the foci was calculated using
the following formula: D = (4/
Q
)·d. Volume density of the
foci was calculated by the following equation: Nv=Na/D.
Livers from three to four animals were analyzed at each
time-point.
Results
Parenchymal ductules can be induced by AAF/CCl4
experiment and DEN administration
We have described the presence of CK7 -/19 + ductules
in the liver parenchyma 3 months after the completion of the
AAF/Ph experiment [5]. The partial hepatectomy of this
model can be replaced by a single, large dose CCl4 poisoning
(chemical hepatectomy). The AAF/CCl4 experimental model
is comparable to the original AAF/Ph experiment [10,11].
Confirming our results on the AAF/Ph model [5], paren-
chymal ductules could be observed in the liver of rats 3
months after the completion of the AAF/CCl4 model (Fig.
3A). To investigate if parenchymal ductules can be induced
by other forms of liver damage, more experimental models
were checked. Surgical partial hepatectomy and CCl4 poi-
soning themselves or allyl alcohol treatment resulted in no
such ductules (data not shown). However, a single large dose
of DEN (200mg/kg) resulted in liver necrosis, and mor-
phologically similar parenchymal ductules in the same dis-
tribution appeared in the liver upon the disappearance of
necrosis (Fig. 3B) and were present up to 3 months during
our observation period (Fig. 3C). They ended up on a he-
patocyte, surrounded by open U-shaped basement mem-
brane (Fig. 3D) as the canals of Hering (Fig. 3E, F) [4].
Characterization of parenchymal ductules (Table 2)
Ductular reactions are quite common in the liver, and the
phenotype of the ductules is rather variable [13]. Although
no reproducible classification of the ductular reactions exists,
certain features are highly characteristic for certain types of
ductules. The canals of Hering in normal, resting rat liver are
characterized by a unique CK7 -/19 + cytokeratin pheno-
type (Fig. 3E, F). The parenchymal ductules also do not ex-
press CK7 (Fig. 4A, B), while the activated oval cells do (Fig.
4C) [5]. There are no SMA expressing myofibroblasts around
the canals of Hering and parenchymal ductules (Fig. 4D, E),
but they are closely associated with the activated oval cells
(Fig. 4F). Alpha-fetoprotein (AFP) (data not shown) and
delta-like protein (DLK) are also not expressed by the canals
of Hering and the parenchymal ductules (Fig. 4G, H) but are
distinctive markers of the oval cells in rat liver (Fig. 4I)
[14,15]. In fact, all the described features of the parenchymal
ductules, except their distribution are consistent with the
resting canals of Hering and are different from their acti-
vated progenies the so called oval cells [5].
Oval cell proliferation/differentiation is advanced
in livers with parenchymal ductules
The canals of Hering are regarded as the niche of hepatic
stem cells [4,15]. We were curious if the presence of the in-
traparenchymal ductules, which had a phenotype similar to
the canals of Hering had any impact on the oval cell prolif-
eration/differentiation triggered by the AAF/CCl4 protocol.
This experiment was performed on three different groups of
rats. The intensity and dynamics of oval cell proliferation
was characterized by the morphometric determination of the
area covered by the ‘‘oval cell specific’’ OV6 antibody (Fig. 5).
To quantitate the hepatocytic differentiation, the number of
Table 2. Immunophenotype of the Ductules
Intraparenchymal ductules
Canals
of hering DENa AAF/CCL4
b
Oval
cells
OV-6 + + + +
CK19 + + + +
CK7 - - - +
SMA - - - +
DLK-1 - - - +
a14 days and 12 weeks after DEN administration.
b12 weeks after AAF/CCL4 experiment.
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FIG. 4. Characterization of ductules present in the liver parenchyma 12 weeks after AAF/CCL4 (A, D, G), DEN (B, E, H)
injury and 8 days after PH in the AAF/PH model (C, F, I). (A) Liver cryosection after the AAF/CCl4 experiment stained for
CK7 (green) and laminin (red). The scattered parenchymal ductules surrounded by laminin are negative for CK7. In contrast
CK7 positive bile ducts are present in the portal tracts. (B) Liver cryosection 12 weeks after DEN treatment stained for CK7
(green) and laminin (red). The parenchymal ductules are negative for CK7. (C) Liver cryosection 8 days after PH (AAF/PH
experiment). The oval cell ductules spreading into the parenchyma are positive for CK7 (green) (red; laminin). SMA positivity
(green) is confined only to vessels of the portal and central areas 12 weeks after AAF/CCL4, (D) and DEN (E) injury. The
parenchymal ductules are not surrounded by SMA positive cells (red; laminin). These ductules (arrows) also lack DLK
expression (G, H) (red; OV-6). In contrast oval cell ductules are surrounded by a large amount of SMA positive cells (green) (F)
and a portion of them is positive for DLK (green) (I). Scale bar for (A–F) 200mm; (G–I) 50mm. AAF/Ph, 2-acetaminofluorene/
partial hepatectomy.
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‘‘small hepatocyte’’ foci was counted in the livers of experi-
mental animals. While the peak of oval cell proliferation was
on days 6 in Groups I and II, (groups with parenchymal
ductules) the highest value was reached on day 12 in the
control (III) group (Fig. 6A). The ductules induced by the
AAF/CCl4 experiment (the second one in group I) showed
all the features of typical oval cell ducts, for example, they
became CK7 and DLK positive and were surrounded by a
large amount of SMA positive cells (Fig. 7). Similarly, while
foci appeared on day 4 after chemical hepatectomy in the
pretreated animals (groups I and II with parenchymal
ductules), they were first seen only on day 10 in controls
(Group III) (Fig. 6B). That is the livers with parenchymal
ductules respond faster to the regenerative trigger.
Expansion of the stem cell compartment
is not carcinogenic per se
Another set of animals from each group were saved for an
additional 10months andwere sacrificed at 15months age. The
FIG. 5. Representative images of the dynamics of the expansion of oval cells and appearance and growth of foci. The three
columns of micrographs correspond to the three models used. DEN-AAF/CCl4, (Group II) (A, D, G), 2, 6, 10 days after
chemical hepatectomy, respectively; 2·AAF/CCl4, (Group I) (B, E, H), 2, 6, 10 days after chemical hepatectomy, respectively;
AAF/CCl4, (Group III) (C, F, I), 2, 6, 10 days after chemical hepatectomy, respectively. (f, foci, green; OV6, red; laminin). Scale
bar for (A–I) 200 mm.
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livers were investigated for the presence of tumors or tumor
precursor lesions. Histological examination of each nodular
lesionwas performed. The result is summarized in Table 3. The
DEN-AAF/CCl4 treatment proved to be an efficient hepato-
carcinogenic protocol but one or two cycles of AAF/CCl4
treatment resulted in only sporadic tumorous liver lesions.
Discussion
We have observed that, after certain manipulations,
ductular structures are present in the rat liver parenchyma;
we propose to call them parenchymal ductules. In addition,
the stem cell mediated regeneration is faster in these livers.
FIG. 6. (A) The dynamics of the expansion
of oval cells in the different injury models 2,
6, 8 and 10 days after chemical hepatectomy
(the bar represents SE). (B) The number of
foci/cm3 of liver in the different injury
models 2, 6, 8 and 10 days after chemical
hepatectomy (the bar represents SE).
FIG. 7. Phenotypic characterization of the ductules present in the liver parenchyma in the three model systems after injury.
(A) DEN-AAF/CCl4 (Group II), 4 days after chemical hepatectomy, (B) 2·AAF/CCl4 (Group I), 4 days after the second
chemical hepatectomy, (C).AAF/CCl4 (Group III), 10 days after the chemical hepatectomy. (A) The ductules present in the liver
parenchyma are surrounded by SMA (green) positive cells (arrows) (red; laminin). (B) A portion of the ductules (arrows) are
positive for DLK (green) (red; OV6). (C) All of the ductules are positive for CK7 (green) (red; laminin) Scale bar for (A–C) 50mm.
62 PAPP ET AL.
The existence of the hepatic stem cell compartment is
mostly accepted, these cells and the hepatocytes play the
major role in liver regeneration. There are several candidate
cell populations for the stem cells [16] but most probably
the canals of Hering constitute the niche for them [4,15]. We
have analyzed these canals in detail and described that in
rat liver they: (i) are strictly confined to the periportal
connective tissue [5] (ii) are characterized by a unique
CK7 -/19 + cytokeratin phenotype. The activated proge-
nies of canals of Hering, the so-called oval cells, (i) spread
into the parenchyma, (ii) become CK7 positive, and (iii)
start to express several marker proteins, for example, AFP
and DLK [14,15] (iv) and are surrounded by SMA positive
myofibroblasts. Ductular reactions are quite common in
hepatic tissue [13,17]. These are morphologically rather
heterogenous reactions probably with different etiologies
and biological functions. Their exact role is still debated,
and there is no generally accepted terminology or classifi-
cation for them. We can observe parenchymal ductules 2
weeks after the administration of a necrogenic dose of DEN
and 3 months after the AAF/CCl4 experiments in otherwise
mostly normal hepatic tissue. These are quite narrow tu-
bules reminiscent of the canals of Hering, except for their
spatial distribution. Their immunophenotype is also iden-
tical: they are (i) CK7 -/19 + , (ii) do not express AFP and
DLK, (iii) are not enwrapped with SMA positive myofi-
broblasts. In addition their terminal tip ends up on a he-
patocyte surrounded by an open U shaped basement
membrane. Based on these features, they might correspond
to hepatic stem cells.
It is reproducibly documented that the stem cells can
participate in liver regeneration when the proliferation of
hepatocytes is suppressed. [18,19]. The AAF/Ph or AAF/
CCl4 are among the most often used experimental models
for stem cell mediated liver regeneration. Ductular prolif-
eration was reported after DEN administration in rat and
monkey liver as well [9,20], while the stem cell compart-
ment is not or hardly activated after partial hepatectomy,
CCl4 poisoning or allyl alcohol treatment [18]. Our results
suggest that, upon the completion of progenitor cell medi-
ated regeneration, when the majority of the oval cells dif-
ferentiate into hepatocytes or disappear by apoptosis, some
of them reverse into the phenotype of resting canals of
Hering. However, different from the original ones, they
reside outside the periportal connective tissue in the lob-
ules. The presence of these structures in the liver can be
considered as the expansion of the stem cell compartment.
Expansion of hepatic progenitor cell compartment has been
reported in rats after portal branch ligation [21]. In human
liver, severe parenchymal damages like steatosis [22] or
HBV infection [23] resulted in similar reactions. TGF beta
has been reported to participate in the regulation of this
reaction and the expression of this multifunctional growth
factor is increased in these experimental models [24]. Ex-
pansion of stem/progenitor cell pool has been observed in
other tissues as well [25]. While the expansion of hemato-
poietic stem cells promoted multilineage hematopoiesis
[26], age-related decline of progenitor cells reduced the re-
generative capacity of kidney [27] and liver [28]. We com-
pared the AAF/CCl4 induced regeneration of unchallenged
livers and livers with parenchymal ductules. Both oval cell
expansion and the formation of hepatocytic foci happened
significantly earlier in the livers with parenchymal ductules,
supporting the idea that the presence of parenchymal
ductules represents really expanded stem cell compartment.
This result opens a new theoretical option for increasing the
endogenous regenerative capacity of the liver. The ampli-
fication of stem/progenitor cell pool carries increased risk
of tumor formation [29–35], although there are contradic-
tory results as well [36]. Our results show that the DEN-
AAF/CCl4 model is as efficient a carcinogenesis model as
the original Solt-Farber model and that the AAF/CCl4
treatment is a powerful tumor promoter. However, the
2 ·AAF/CCl4 treated rats did not have significantly more
tumors than the controls. Thus, the increased number of
stem cells does not indicate persistently higher tumor inci-
dence. The recently revealed new results about the regula-
tion of the stem cell compartment [31–36] may give us the
tool to safely expand the pool of these cells in liver, which
may result in clinically applicable increased regenerative
capacity.
Finally, the presence of parenchymal ductules can repre-
sent an imprint of an earlier liver damage. Interestingly,
multigenerational epigenetic adaptation of the hepatic fi-
brotic response has been reported [37] recently. The pro-
genitor cell mediated accelerated liver regeneration in
response to repeated challenges may also indicate a similar
adaptation. Its transgenerational nature and molecular
mechanism will, however, require further studies.
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